This study is testing a medicine called ecopipam for people with Tourette's Disorder (TD). TD is a condition where people have motor and vocal tics, which are sudden movements or sounds they can't control. The study begins with everyone taking ecopipam openly, followed by some receiving a placebo (a harmless pill with no medicine) without knowing, to see if ecopipam works well and is safe. Study Details:
- **Open-label Period:** First, everyone takes ecopipam for 12 weeks.
- **Randomized Withdrawal Period:** For the next 12 weeks, some will continue ecopipam while others receive a placebo.
- **Eligibility:** Participants must be 6 years or older and weigh at least 40 lbs. They should have TD with motor and vocal tics. Key Points:
- The study lasts about 6 months with regular doctor visits. - Participants cannot take other medicines for tics during the study. - There are safety checks throughout the study to ensure well-being. This study aims to find out if ecopipam can help manage tics in people with Tourette's Disorder in a safe way.
How understandable was the trial content above?
Hard to understand
Easy to understand